Martin Van Trieste

Chief Executive Officer at Civica Rx

Martin Van Trieste

Martin Van Trieste

Chief Executive Officer at Civica Rx

Overview
Career Highlights

Civica Rx
Rx-360

RelSci Relationships

1464

Number of Boards

4

Contact Data
Trying to get in touch with Martin Van Trieste? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Martin Van Trieste likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Vice President, Quality at Hospira, Inc.

Relationship likelihood: Strong

Manager, Global Quality Strategy at Pfizer, Inc.

Relationship likelihood: Strong

Co-Founder at rfXcel Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at Pharmaceutical Research and Manufacturers of America

Relationship likelihood: Strong

Executive Vice President & General Counsel at Pharmaceutical Research and Manufacturers of America

Relationship likelihood: Strong

Executive Partner at Cardinal Equity Partners LLC

Relationship likelihood: Strong

Director at Parenteral Drug Association

Relationship likelihood: Strong

Director at Parenteral Drug Association

Relationship likelihood: Strong

Vice President-Marketing at Ignis Optics, Inc.

Relationship likelihood: Strong

President at Takeda Pharmaceuticals U.S.A., Inc.

Relationship likelihood: Strong

Paths to Martin Van Trieste
Potential Connections via
Relationship Science
You
Martin Van Trieste
Chief Executive Officer at Civica Rx
Education
Memberships
Member, Aseptic Processing Working Group
Career History
Chief Executive Officer
2018 - Current
Vice President of Quality Assurance, Hospital Products Division
1983 - Prior

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Founder
Prior

THE MISSION OF RX-360 IS TO PROTECT PATIENT SAFETY BY SHARING INFORMATION AND DEVELOPING PROCESSES TO IMPROVE THE INTEGRITY OF THE HEALTH CARE SUPPLY CHAIN AND THE QUALITY OF MATERIALS WITHIN THE HEALTH CARE SUPPLY CHAIN.

Boards & Committees
Director
Prior

THE MISSION OF RX-360 IS TO PROTECT PATIENT SAFETY BY SHARING INFORMATION AND DEVELOPING PROCESSES TO IMPROVE THE INTEGRITY OF THE HEALTH CARE SUPPLY CHAIN AND THE QUALITY OF MATERIALS WITHIN THE HEALTH CARE SUPPLY CHAIN.

Events
Speaker
2014 ExcipientFest Presentations

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Martin Van Trieste. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Martin Van Trieste's profile does not indicate a business or promotional relationship of any kind between RelSci and Martin Van Trieste.